The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA approves schizophrenia treatment
The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis